...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
【24h】

Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

机译:肽酶通过内源性释放的阿片类药物阻止背角神经元中的阿片类受体内在化。

获取原文
获取原文并翻译 | 示例

摘要

To evaluate the effect of peptidases on mu-opioid receptor (MOR) activation by endogenous opioids, we measured MOR-1 internalization in rat spinal cord slices. A mixture of inhibitors of aminopeptidases (amastatin), dipeptidyl carboxypeptidase (captopril), and neutral endopeptidase (phosphoramidon) dramatically increased the potencies of Leu-enkephalin and dynorphin A to produce MOR-1 internalization, and also enhanced the effects of Met-enkephalin and alpha-neoendorphin, but not endomorphins or beta-endorphin. The omission of any one inhibitor abolished Leu-enkephalin-induced internalization, indicating that all three peptidases degraded enkephalins. Amastatin preserved dynorphin A-induced internalization, and phosphoramidon, but not captopril, increased this effect, indicating that the effect of dynorphin A was prevented by aminopeptidases and neutral endopeptidase. Veratridine (30 microm) or 50 mm KCl produced MOR-1 internalization in the presence of peptidase inhibitors, but little or no internalization in their absence. These effects were attributed to opioid release, because they were abolished by the selective MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2)) and were Ca(2+) dependent. The effect of veratridine was protected by phosphoramidon plus amastatin or captopril, but not by amastatin plus captopril or by phosphoramidon alone, indicating that released opioids are primarily cleaved by neutral endopeptidase, with a lesser involvement of aminopeptidases and dipeptidyl carboxypeptidase. Therefore, because the potencies of endomorphin-1 and endomorphin-2 to elicit internalization were unaffected by peptidase inhibitors, the opioids released by veratridine were not endomorphins. Confocal microscopy revealed that MOR-1-expressing neurons were in close proximity to terminals containing opioids with enkephalin-like sequences. These findings indicate that peptidases prevent the activation of extrasynaptic MOR-1 in dorsal horn neurons.
机译:为了评估肽酶对内源性阿片样物质对阿片样物质受体(MOR)活化的影响,我们测量了大鼠脊髓切片中的MOR-1内在化。氨基肽酶(阿马他汀),二肽基羧肽酶(卡托普利)和中性内肽酶(磷酰胺)的抑制剂混合物显着增加了亮脑啡肽和强啡肽A产生MOR-1内在化的能力,还增强了Met-脑啡肽和α-新内啡肽,但不是内啡肽或β-内啡肽。省略任何一种抑制剂都消除了Leu-脑啡肽诱导的内在化,表明所有三种肽酶均降解了脑啡肽。 Amastatin保留了强啡肽A诱导的内在化作用,而磷酰胺,而不是卡托普利,则增强了这种作用,表明强肽A的作用被氨基肽酶和中性内肽酶所阻止。在肽酶抑制剂存在下,Veratridine(30 microm)或50 mm KCl产生了MOR-1内部化,但在不存在肽酶抑制剂的情况下几乎没有或没有内部化。这些作用归因于阿片样物质的释放,因为它们被选择性的MOR拮抗剂CTAP(D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2))取消,并且是Ca(2+ )依赖。维拉替丁的作用受磷酰胺加阿马斯汀或卡托普利的保护,但不受阿马斯汀加卡托普利或仅磷酰胺的保护,这表明释放的阿片类药物主要被中性内肽酶切割,而氨基肽酶和二肽基羧肽酶的参与较少。因此,由于内啡肽-1和内啡肽-2引起内在化的能力不受肽酶抑制剂的影响,因此维拉替丁释放的阿片类药物不是内啡肽。共聚焦显微镜检查发现,表达MOR-1的神经元与含有类脑啡肽序列的阿片样物质的末端非常接近。这些发现表明,肽酶阻止了背角神经元中突触外突触MOR-1的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号